UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
40-F
☐
|
Registration statement pursuant to Section 12 of the Securities Exchange Act of 1934
|
or
☒
|
Annual report pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934
|
For the fiscal year ended December
31, 2018
Commission File Number
001-38524
Titan Medical Inc.
(Exact name of Registrant as specified in its charter)
|
|
|
|
|
Ontario, Canada
|
|
3841
|
|
98-0663504
|
(Province or other jurisdiction of
incorporation or organization)
|
|
(Primary Standard Industrial
Classification Code Number)
|
|
(I.R.S. Employer
Identification Number)
|
170 University Avenue, Suite 1000
Toronto, Ontario M5H 3B3
Canada
(416)
548-7522
(Address and telephone number of Registrants principal executive offices)
CT Corporation System
1015 15
th
Street N.W., Suite 1000
Washington, DC 20005
(202)
572-3100
(Name, address (including zip code) and telephone number (including area code)
of agent for service in the United States)
Securities registered or to be registered pursuant to Section 12(b) of the Act:
|
|
|
Title of each class
|
|
Name of each exchange on which
registered
|
Common Shares, no par value
|
|
The NASDAQ Stock Market LLC
|
Securities registered pursuant to Section 12(g) of the Act: None.
Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act: None
For annual reports, indicate by check mark the information filed with this Form:
|
|
|
☒
Annual information form
|
|
☒
Audited annual financial statements
|
Indicate the number of outstanding shares of each of the registrants classes of capital or common stock as of the close of the period covered by the
annual report:
21,675,849
Indicate by check
mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and
(2) has been subject to such filing requirements for the past 90 days.
☒ Yes ☐ No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405
of Regulation
S-T
(§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files).
☐ Yes ☐ No
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule
12b-2
of the Exchange
Act.
Emerging growth company ☒
If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected
not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
|
The term new or revised financial accounting standard refers to any update issued by the Financial
Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.
|